HK1255123A1 - 具有患者衍生異種移植物的非hla匹配的人源化nsg小鼠模型 - Google Patents

具有患者衍生異種移植物的非hla匹配的人源化nsg小鼠模型

Info

Publication number
HK1255123A1
HK1255123A1 HK18113881.5A HK18113881A HK1255123A1 HK 1255123 A1 HK1255123 A1 HK 1255123A1 HK 18113881 A HK18113881 A HK 18113881A HK 1255123 A1 HK1255123 A1 HK 1255123A1
Authority
HK
Hong Kong
Prior art keywords
patient
mouse model
derived xenograft
nsg mouse
hla matched
Prior art date
Application number
HK18113881.5A
Other languages
English (en)
Inventor
James Keck
Original Assignee
Jackson Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jackson Lab filed Critical Jackson Lab
Publication of HK1255123A1 publication Critical patent/HK1255123A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0362—Animal model for lipid/glucose metabolism, e.g. obesity, type-2 diabetes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0387—Animal model for diseases of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C12N2015/8518—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
HK18113881.5A 2015-06-23 2018-10-30 具有患者衍生異種移植物的非hla匹配的人源化nsg小鼠模型 HK1255123A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562183386P 2015-06-23 2015-06-23
PCT/US2016/038622 WO2016209865A1 (en) 2015-06-23 2016-06-22 Non-hla matched humanized nsg mouse model with patient-derived xenograft

Publications (1)

Publication Number Publication Date
HK1255123A1 true HK1255123A1 (zh) 2019-08-02

Family

ID=56404302

Family Applications (2)

Application Number Title Priority Date Filing Date
HK18113198.3A HK1254127A1 (zh) 2015-06-23 2018-10-15 具有患者衍生異種移植物的非hla匹配的人源化nsg小鼠模型
HK18113881.5A HK1255123A1 (zh) 2015-06-23 2018-10-30 具有患者衍生異種移植物的非hla匹配的人源化nsg小鼠模型

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK18113198.3A HK1254127A1 (zh) 2015-06-23 2018-10-15 具有患者衍生異種移植物的非hla匹配的人源化nsg小鼠模型

Country Status (13)

Country Link
US (3) US11248236B2 (zh)
EP (1) EP3313175A1 (zh)
JP (1) JP6813514B2 (zh)
KR (2) KR102664078B1 (zh)
CN (1) CN107920500B (zh)
AU (3) AU2016284205B2 (zh)
CA (1) CA2989839A1 (zh)
HK (2) HK1254127A1 (zh)
IL (1) IL256342B2 (zh)
RU (1) RU2757421C2 (zh)
SG (1) SG10201911694TA (zh)
TW (1) TWI810145B (zh)
WO (1) WO2016209865A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7458185B2 (ja) * 2016-11-30 2024-03-29 ザ ジャクソン ラボラトリー 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル
FI3612840T3 (fi) 2017-04-17 2023-03-22 Menetelmä ihmisillä käytettävän immuunivasteen muuntavan lääkkeen toksisuuden määrittämiseksi
KR102226485B1 (ko) * 2017-05-29 2021-03-11 연세대학교 산학협력단 유방암 환자 종양 유래 이종이식 모델의 제조방법
US20210147810A1 (en) * 2017-06-28 2021-05-20 Rutgers, The State University Of New Jersey Single lung cell-derived organoids
WO2019006136A1 (en) * 2017-06-28 2019-01-03 Rutgers, The State University Of New Jersey ORGANOIDS DERIVED FROM A SINGLE VESIC CELL
JP7404237B2 (ja) * 2017-08-09 2023-12-25 ザ ジャクソン ラボラトリー ヒトインターロイキン１５を発現する免疫不全マウス
US20210153484A1 (en) * 2018-04-09 2021-05-27 The Wistar lnstitute Humanized Mouse Model
WO2021097203A1 (en) * 2019-11-15 2021-05-20 Board Of Regents, The University Of Texas System Humanized mouse model with human immune system
CN111485001A (zh) * 2020-04-14 2020-08-04 澎立生物医药技术（上海）有限公司 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法
CN113264996A (zh) * 2020-04-30 2021-08-17 百奥赛图(北京)医药科技股份有限公司 一种人源化的非人动物及其制备方法和应用
CN111713450B (zh) * 2020-05-26 2022-07-12 上海交通大学医学院 一种慢性粒细胞白血病的pdx模型的建立方法
WO2022066894A1 (en) * 2020-09-24 2022-03-31 The Jackson Laboratory Humanized mouse models for assessing immune cell therapy
CN113951212A (zh) * 2020-10-30 2022-01-21 浙江省肿瘤医院 一种her2阳性胃癌耐药pdx模型及其构建方法与应用
EP4255577A1 (en) * 2020-12-07 2023-10-11 The Jackson Laboratory Infectious disease mouse models
WO2023122138A1 (en) * 2021-12-22 2023-06-29 The Jackson Laboratory Humanized mouse models
WO2023225153A1 (en) * 2022-05-19 2023-11-23 The Jackson Laboratory Transgenic mouse models of human adaptive and innate immunity and methods of use
WO2024054904A1 (en) * 2022-09-08 2024-03-14 The Jackson Laboratory Humanized immunodeficient mouse models
WO2024112158A1 (ko) * 2022-11-25 2024-05-30 가톨릭대학교 산학협력단 암환자 면역모사 아바타 시스템을 이용한 면역항암제 평가플랫폼

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2451637C (en) * 2001-06-22 2013-04-23 Stemcells, Inc. Liver engrafting cells, assays, and uses thereof
AU2004263079A1 (en) 2003-07-10 2005-02-17 Center For The Advancement Of Health And Biosciences Animal model for the analysis of tumor metastasis
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
SG10202008003VA (en) * 2011-02-15 2020-10-29 Regeneron Pharma Humanized m-csf mice
US20150283269A1 (en) * 2014-04-04 2015-10-08 Crown Bioscience Inc. Reconstituted human immune system in a patient derived xenograft mouse model

Also Published As

Publication number Publication date
US11248236B2 (en) 2022-02-15
AU2022201100B2 (en) 2024-04-04
JP6813514B2 (ja) 2021-01-13
IL256342B (en) 2022-12-01
AU2016284205B2 (en) 2021-12-02
KR102664078B1 (ko) 2024-05-10
JP2018524981A (ja) 2018-09-06
TWI810145B (zh) 2023-08-01
IL256342A (en) 2018-02-28
AU2022201100A1 (en) 2022-03-10
CA2989839A1 (en) 2016-12-29
CN107920500A (zh) 2018-04-17
SG10201911694TA (en) 2020-02-27
HK1254127A1 (zh) 2019-07-12
TW201718852A (zh) 2017-06-01
EP3313175A1 (en) 2018-05-02
US20180187210A1 (en) 2018-07-05
KR20180019645A (ko) 2018-02-26
US20220127639A1 (en) 2022-04-28
IL256342B2 (en) 2023-04-01
CN107920500B (zh) 2021-02-05
KR20240068768A (ko) 2024-05-17
WO2016209865A1 (en) 2016-12-29
AU2016284205A1 (en) 2018-01-18
RU2018101316A (ru) 2019-07-24
US20220127638A1 (en) 2022-04-28
RU2018101316A3 (zh) 2019-11-11
RU2757421C2 (ru) 2021-10-15
AU2024201769A1 (en) 2024-04-04

Similar Documents

Publication Publication Date Title
HK1255123A1 (zh) 具有患者衍生異種移植物的非hla匹配的人源化nsg小鼠模型
IL252004A0 (en) Ether-substituted antibody
IL250461A0 (en) Anti-cll-1 antibodies and immunoconjugates
DK3191517T3 (da) Krydsreaktive siglec-antistoffer
DK3038002T3 (da) Interaktive brugergrænseflader
GB2533004B (en) Characterising motion constraints
GB201411320D0 (en) Antibody construct
HK1214750A1 (zh) 呼吸運動測定裝置
DK3140653T3 (da) Direkte immunhistokemianalyse
ZA201701461B (en) Antibody formulations
IL291164A (en) Anti-nme antibody
PT3101132T (pt) Anticorpo humano anti-transtirretina
PT3117245T (pt) Sensor sísmico
GB201410520D0 (en) Antibody
PL3180356T3 (pl) Ludzkie przeciwciało anty-fgfr4
SG11201700922YA (en) Anti-orai1 antibody
GB201608056D0 (en) Improved analysis with preliminary survey
AP00715S1 (en) Toy construction element
PL3170184T3 (pl) Całkowita zintegrowana analiza rur
GB2528694B (en) Turnstiles
IL248488A0 (en) track cleaner
GB201415526D0 (en) Antibody Formulations
GB201415298D0 (en) Antibody Formulations
GB201418776D0 (en) Antibody
GB201412241D0 (en) Motion emulator